Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Neoplasms × combretastatin × 30 days × Clear all

Sponsor

Interventions

lenvatinib 3 trametinib 2 pembrolizumab 2 anlotinib 2 Specimen Handling 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Cyclophosphamide 2 Biopsy 2 tremelimumab 1 trastuzumab deruxtecan 1 selpercatinib 1 pralsetinib 1 naporafenib 1 gallium Ga 68 dotatate 1 fludarabine phosphate 1 durvalumab 1 defactinib 1 dabrafenib 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sorafenib 1 Radiotherapy 1 Neck Dissection 1 Molecular Diagnostic Techniques 1 Ipilimumab 1 Interleukin-13 1 Fluorodeoxyglucose F18 1 Eye Movement Desensitization Reprocessing 1 Etoposide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡